pfmmedical invests in Lyra Medical to propel innovation in Pelvic Organ Prolapse treatment
08/03/2023
pfm medical ag, an international medical technology specialist based in Cologne, invested in an Israeli company, Lyra Medical Ltd. in May 2023.
In its prime area of focus, SURGERY, pfmmedical is a leading name in prolapse surgery, for anterior prolapse with or without the involvement of the apical compartment. With the aid of the SRS (SELF RETAINING SUPPORT) Implant and a titanised type 1a surgical mesh, patients can be treated using the revolutionary surgical, yet minimally invasive method without the use of anchoring or fixation. The manufacturer of the SRS Implant, which is distributed in Germany exclusively by pfmmedical, is Lyra Medical Ltd. The partnership between pfmmedical and Lyra Medical was initiated in July 2018.
“pfmmedical has been active in pelvic floor surgery for many years. Globally, around 200,000 of our titanised pelvic floor meshes have been implanted in the past 10 years. We are very happy about the strategic investment and will continue to forge the path ahead with Lyra Medical,” says Aurel Schoeller, Chairman of the Management Board of pfm medical ag. The SRS Implant is a new generation of a transvaginal implant with a range of advantages for its users, patients and the health system in general. “The anchorless technology imitates the patient’s natural anatomy, brings the pelvic organs back into their anatomical and functional locations, without the potential complications associated with mesh anchoring,” says Iram Levit, co-founder and CEO of Lyra Medical, describing the product’s advantages. “Our strategic alliance with pfmmedical brings together Lyra's innovative product with pfmmedical's vast sales, marketing and development experience. This powerful combination enables us to reach more markets and improve patient care on a global scale.", he continued.
In addition to the investment, pfmmedical has also been granted a position on the Lyra Medical Board of Directors. The existing distribution agreement was also mutually extended until 31 March 2026. pfmmedical thus remains the exclusive distributor in Germany, Austria, Switzerland, Italy, Spain and Sweden.
For more information about Lyra Medical and its SRS Implant, please visit https://lyramedical.com/ and https://www.pfmmedical.com/SRS .
-----------------------
About pfmmedical
pfmmedical is one of the leading German providers of special solutions in the healthcare sector. The Cologne-based family-owned company was founded in 1971, and has 660 employees at twelve international locations. The medical product provider holds 370 granted property rights in over 90 patent families worldwide and distributes a broad portfolio in more than 100 markets.
Its products span the following four medical focus fields: Surgery (e.g. drainage systems and titanised mesh implants), infusion (e.g. mobile electronic infusion pumps and implantable port catheters), histotechnology (e.g. blades and laboratory equipment) and cardiovascular technology (e.g. implantable occlusion devices for the interventional treatment of congenital heart disease and special catheters).
pfmmedical combines products and services to a comprehensive package of solutions. For instance, the company provides training and advice to users such as medical practitioners, nursing staff, patients and their families to support optimal therapy outcomes in both inpatient and outpatient healthcare. When developing innovative solutions in close cooperation with leading medical practitioners and specialist partners, pfmmedical invariably focuses on improving the quality of life of both users and patients.
Press Contact
pfm medical ag
Martina Welters
Wankelstraße 60
50996 Köln
Tel.: +49 2236 9641-370
martina.welters[at]pfmmedical.com